WO2006024449A3 - Diagnostic et traitement des maladies associees au recepteur 1 de cysteinyl leucotriene (cyslt1) - Google Patents
Diagnostic et traitement des maladies associees au recepteur 1 de cysteinyl leucotriene (cyslt1) Download PDFInfo
- Publication number
- WO2006024449A3 WO2006024449A3 PCT/EP2005/009164 EP2005009164W WO2006024449A3 WO 2006024449 A3 WO2006024449 A3 WO 2006024449A3 EP 2005009164 W EP2005009164 W EP 2005009164W WO 2006024449 A3 WO2006024449 A3 WO 2006024449A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- diseases
- cyslt1
- therapeutics
- diagnostics
- diseases associated
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04020739.1 | 2004-09-01 | ||
EP04020739 | 2004-09-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006024449A2 WO2006024449A2 (fr) | 2006-03-09 |
WO2006024449A3 true WO2006024449A3 (fr) | 2006-06-22 |
Family
ID=35598380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/009164 WO2006024449A2 (fr) | 2004-09-01 | 2005-08-25 | Diagnostic et traitement des maladies associees au recepteur 1 de cysteinyl leucotriene (cyslt1) |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006024449A2 (fr) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001031014A2 (fr) * | 1999-10-27 | 2001-05-03 | Pharmacia & Upjohn Company | Recepteurs couples par des proteines g exprimes dans le cerveau |
-
2005
- 2005-08-25 WO PCT/EP2005/009164 patent/WO2006024449A2/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001031014A2 (fr) * | 1999-10-27 | 2001-05-03 | Pharmacia & Upjohn Company | Recepteurs couples par des proteines g exprimes dans le cerveau |
Non-Patent Citations (5)
Title |
---|
CAPRA VALERIE: "Molecular and functional aspects of human cysteinyl leukotriene receptors", PHARMACOLOGICAL RESEARCH, vol. 50, no. 1, July 2004 (2004-07-01), pages 1 - 11, XP002364368, ISSN: 1043-6618 * |
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 2001, NOTHACKER H P ET AL: "Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: Discovery of a subtype selective agonist", XP002364378, Database accession no. PREV200100491239 * |
KLEGERIS A ET AL: "Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAP", JOURNAL OF LEUKOCYTE BIOLOGY 01 MAR 2003 UNITED STATES, vol. 73, no. 3, 1 March 2003 (2003-03-01), pages 369 - 378, XP009060568, ISSN: 0741-5400 * |
SOCIETY FOR NEUROSCIENCE ABSTRACTS, vol. 27, no. 1, 2001, 31ST ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE; SAN DIEGO, CALIFORNIA, USA; NOVEMBER 10-15, 2001, pages 688, ISSN: 0190-5295 * |
ZHANG WEI-PING ET AL: "Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats", ACTA PHARMACOLOGICA SINICA, vol. 23, no. 10, October 2002 (2002-10-01), pages 871 - 877, XP002364367, ISSN: 1671-4083 * |
Also Published As
Publication number | Publication date |
---|---|
WO2006024449A2 (fr) | 2006-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006027147A3 (fr) | Agents diagnostiques et therapeutiques destines a des maladies associees au recepteur d'adrenomedulline (amdr) | |
WO2005093092A3 (fr) | Diagnostic et traitement de maladies associees au recepteur 44 couple aux proteines g (gpr44) | |
WO2005106012A3 (fr) | Diagnostics et therapeutiques de maladies associees a la dipeptidyl-peptidase 1 (dpp1) | |
WO2006010517A3 (fr) | Diagnostic et traitement therapeutique des maladies associees a la proteine d'activation des fibroblastes (fap) | |
WO2006005469A3 (fr) | Methodes diagnostiques et therapeutiques pour lutter contre les maladies associees au recepteur de glucagon (gcgr) | |
WO2005100990A3 (fr) | Methodes diagnostiques et therapeutiques pour des maladies associees au purinocepteur 2 de type y (p2y2) | |
WO2005106491A3 (fr) | Diagnostic et traitement therapeutique de maladies associees a la kinase 1 regulee par serum/glucocorticoide (sgk1) | |
WO2005103684A3 (fr) | Diagnostics et methodes therapeutiqeus pour des maladies associees au recepteur 1 de la chimiokine cx3c | |
WO2006021343A3 (fr) | Diagnostic et therapie de maladies associees au recepteur 3a de la 5-hydroxytryptamine (5-ht3a) | |
WO2005076007A3 (fr) | Diagnostics et traitements de maladies associees au recepteur p2y12 couple a la proteine g (p2y12) | |
WO2005101001A3 (fr) | Methodes diagnostiques et therapeutiques pour lutter contre des maladies associees au recepteur couple a la proteine g, element c, groupe 5, famille c (gprc5c) | |
WO2005113786A3 (fr) | Methodes diagnostiques et therapeutiques pour lutter contre des maladies associees a la chymase (cma1) | |
WO2005093091A3 (fr) | Agents diagnostiques et therapeutiques pour maladies associees au recepteur 26 couple a la proteine g (gpr26) | |
WO2005074969A3 (fr) | Diagnostics et traitements de maladies associees au recepteur nucleaire humain nr4a1 (nr4a1) | |
WO2005031345A3 (fr) | Diagnostic et therapeutique de maladies associees au recepteur couple a la proteine g adipor2 (adipor2) | |
WO2005073729A3 (fr) | Diagnostic et traitement de maladies associees au recepteur p2y11 couple a une proteine g (p2y11) | |
WO2005106486A3 (fr) | Diagnostics et therapeutiques de maladies associees a la dipeptidyl-peptidase 3 (dpp3) | |
WO2006005470A3 (fr) | Agents diagnostiques et therapeutiques pour des maladies associees au recepteur couple a la proteine g lie au mas (mrge) | |
WO2005101011A3 (fr) | Agents diagnostiques therapeutiques pour des maladies associees a lxr-alpha (lxra) | |
WO2005113788A3 (fr) | Diagnostics et therapeutiques pour des maladies associees a la kinase 6 associee au recepteur couple a une proteine g (grk6) | |
WO2006024449A3 (fr) | Diagnostic et traitement des maladies associees au recepteur 1 de cysteinyl leucotriene (cyslt1) | |
WO2005101009A3 (fr) | Outils diagnostiques et therapeutiques pour maladies associees au recepteur 2 de tachykinine (tacr2) | |
WO2005100997A3 (fr) | Moyens diagnostiques et therapeutiques pour maladies associees au recepteur de tachykinine 3 (tacr3) | |
WO2006010515A3 (fr) | Diagnostic et traitement therapeutique des maladies associees a la 5-hydroxytryptamine 2a (5ht2a) | |
WO2005119263A3 (fr) | Diagnostic et traitement des maladies associees au recepteur couple aux proteines g 92 (gpr92) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |